Nanox Imaging
Neve Ilan
About Nanox Imaging
Nanox offers the Nanox System as a preventative healthcare Medical Screening As A Service (MSaaS). Nanox field-effect cathode technology was originally developed for use in high-definition flat panel displays. Over time, the manufacturing processes were ported from glass to silicon, enabling enormous increases in power density and uniformity. After more than 20 years of research and development, with over $1B invested, their team of engineers has developed unique intellectual property, patents, and capability to design and build high-powered field-effect cathodes that outperform all previous efforts. Nanox’s proprietary cold cathode technology greatly expands the capabilities of X-ray imaging. At the core of their high-powered cold cathode is a “chip” of nano-scale structures created using proprietary nanofabrication techniques. The chip is designed to support various use cases of medical imaging and will be supported by peripheral technologies in order to translate their benefits into various real-world applications.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $165.1M
- Funding stage: IPO
- Last round: Post-IPO Equity (Nov 2025)
- Ticker: nasdaq:NNOX
- Website: nanox.vision
- Phone: +972-350 2004-0000
Industries & Categories
Health Care, Medical, Medical Device, Nanotechnology, Semiconductor
Social Profiles
Canonical: https://fsome.com/organization/nanox-imaging-79335 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.